Free Trial

TNF Pharmaceuticals (TNFA) Competitors

$0.48 -0.01 (-2.62%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$0.48 +0.00 (+0.42%)
As of 02/21/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TNFA vs. AWH, ABVC, FRTX, KZIA, ONVO, VRAX, ELAB, ONCO, LIXT, and PRTG

Should you be buying TNF Pharmaceuticals stock or one of its competitors? The main competitors of TNF Pharmaceuticals include Aspira Women's Health (AWH), ABVC BioPharma (ABVC), Fresh Tracks Therapeutics (FRTX), Kazia Therapeutics (KZIA), Organovo (ONVO), Virax Biolabs Group (VRAX), Elevai Labs (ELAB), Onconetix (ONCO), Lixte Biotechnology (LIXT), and Portage Biotech (PRTG). These companies are all part of the "pharmaceutical products" industry.

TNF Pharmaceuticals vs.

TNF Pharmaceuticals (NASDAQ:TNFA) and Aspira Women's Health (NASDAQ:AWH) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, community ranking, institutional ownership, earnings, profitability and risk.

In the previous week, TNF Pharmaceuticals' average media sentiment score of 0.00 beat Aspira Women's Health's score of -0.27 indicating that TNF Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
TNF Pharmaceuticals Neutral
Aspira Women's Health Neutral

Aspira Women's Health received 14 more outperform votes than TNF Pharmaceuticals when rated by MarketBeat users.

CompanyUnderperformOutperform
TNF PharmaceuticalsN/AN/A
Aspira Women's HealthOutperform Votes
14
17.72%
Underperform Votes
65
82.28%

TNF Pharmaceuticals has a net margin of 0.00% compared to Aspira Women's Health's net margin of -165.07%. Aspira Women's Health's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
TNF PharmaceuticalsN/A -180.71% -84.27%
Aspira Women's Health -165.07%N/A -267.23%

9.6% of TNF Pharmaceuticals shares are held by institutional investors. Comparatively, 12.2% of Aspira Women's Health shares are held by institutional investors. 1.2% of TNF Pharmaceuticals shares are held by insiders. Comparatively, 4.3% of Aspira Women's Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

TNF Pharmaceuticals has higher earnings, but lower revenue than Aspira Women's Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TNF PharmaceuticalsN/AN/A-$4MN/AN/A
Aspira Women's Health$9.15M0.42-$16.69M-$1.20-0.18

TNF Pharmaceuticals has a beta of 2.13, meaning that its share price is 113% more volatile than the S&P 500. Comparatively, Aspira Women's Health has a beta of 1.38, meaning that its share price is 38% more volatile than the S&P 500.

Aspira Women's Health has a consensus price target of $4.40, indicating a potential upside of 1,927.65%. Given Aspira Women's Health's stronger consensus rating and higher probable upside, analysts clearly believe Aspira Women's Health is more favorable than TNF Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TNF Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aspira Women's Health
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Aspira Women's Health beats TNF Pharmaceuticals on 8 of the 13 factors compared between the two stocks.

Get TNF Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TNFA vs. The Competition

MetricTNF PharmaceuticalsDiagnostic substances IndustryMedical SectorNASDAQ Exchange
Market Cap$1.32M$2.30B$5.84B$9.14B
Dividend YieldN/A0.75%4.76%3.85%
P/E RatioN/A2.5218.2614.95
Price / SalesN/A91.51434.4770.76
Price / CashN/A15.7538.4235.17
Price / Book0.073.287.644.65
Net Income-$4M-$65.73M$3.18B$245.69M
7 Day Performance-16.02%-3.90%-1.95%-2.68%
1 Month Performance-57.98%-8.97%-0.23%-2.16%
1 Year PerformanceN/A-15.59%16.69%12.90%

TNF Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TNFA
TNF Pharmaceuticals
N/A$0.48
-2.6%
N/AN/A$1.32MN/A0.006
AWH
Aspira Women's Health
1.0928 of 5 stars
$0.34
-4.2%
$4.40
+1,209.5%
-95.3%$5.60M$9.15M-0.28110Gap Up
ABVC
ABVC BioPharma
1.1387 of 5 stars
$0.43
-2.1%
N/A-41.2%$5.56M$150,000.00-0.5030News Coverage
Positive News
Gap Down
FRTX
Fresh Tracks Therapeutics
N/A$0.93
-0.3%
N/A-1.1%$5.55M$8.01M-0.6620
KZIA
Kazia Therapeutics
3.2305 of 5 stars
$1.08
-14.7%
$11.50
+969.8%
-72.1%$5.42M$1.51M0.0012
ONVO
Organovo
1.1238 of 5 stars
$0.35
-0.3%
N/A-63.1%$5.36M$110,000.00-0.3320Earnings Report
VRAX
Virax Biolabs Group
0.8513 of 5 stars
$1.64
-3.9%
N/A+93.9%$5.31M$160,000.000.005
ELAB
Elevai Labs
0.0936 of 5 stars
$1.71
-9.3%
N/A-98.9%$5.23M$1.71M-0.0318
ONCO
Onconetix
0.5404 of 5 stars
$0.62
+1.3%
N/A-94.4%$5.14M$1.87M0.0012News Coverage
Positive News
LIXT
Lixte Biotechnology
0.2018 of 5 stars
$2.29
-7.1%
N/A-45.3%$5.14MN/A-1.324Gap Up
PRTG
Portage Biotech
0.0827 of 5 stars
$4.69
-0.4%
N/A-46.0%$5.13MN/A-0.126Upcoming Earnings
Gap Down

Related Companies and Tools


This page (NASDAQ:TNFA) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners